Brammer Bio

Apr 02, 2019

Sangamo Announces Agreement Securing Access To Large-Scale, Commercial-Grade Manufacturing Capacity At Brammer Bio

Mar 24, 2019

Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing

Feb 28, 2019

Brammer Bio Supports Rare Disease Day

Jan 08, 2019

DPS Group Selected to Design Two cGMP Commercial Manufacturing Facilities for Brammer Bio

Jan 03, 2019

Brammer Bolsters Leadership Team and Announces Chief Quality Officer

Nov 28, 2018

Brammer Bio is Named Manufacturing Company of the Year

Sep 26, 2018

Brammer Bio announces progress on $200 million program to advance gene therapies

Mar 20, 2018

Brammer Bio Expands Leadership Team for Commercial Readiness

Feb 28, 2018

Brammer Bio Supports Rare Disease Day 2018

Nov 27, 2017

Brammer Bio Launches Gene Therapy Product Manufacturing Operations in Massachusetts

Nov 09, 2017

Sangamo Announces Strategic Investment In Manufacturing And Appointment Of Andy Ramelmeier As Head Of Technical Operations

Sep 18, 2017

Brammer Bio Completes Expansion of Cell and Gene Therapy Clinical Manufacturing Facilities in Florida

Jun 20, 2017

Brammer Bio Appoints Leading Commercial Manufacturing And Gene Therapy Expert As Chief Manufacturing Officer